Product Images Rituxan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Rituxan NDC 50242-053 by Genentech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - rituxan 01

Figure 1 - rituxan 01

Figure 2 - rituxan 02

Figure 2 - rituxan 02

This text represents a graph or a chart that shows the percentage of ACR 20 Responders after receiving either a placebo or a 2x1000mg dose of Rituxan at different time points (from 0 to 24 weeks).*

Figure 3 - rituxan 03

Figure 3 - rituxan 03

PRINCIPAL DISPLAY PANEL - 100 mg Vial Carton - rituxan 04

PRINCIPAL DISPLAY PANEL - 100 mg Vial Carton - rituxan 04

This is a product information for Rituxan® (rituximab) Injection, which is identified by NDC 50242-051-21. It comes in a 100 mg/10mL (10 mg/mL) vial for intravenous use. The product is marked with an "R" indicating it is available only by prescription.*

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton - rituxan 05

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton - rituxan 05

This is a medication called Rituxan® (rituximab) which is available in injection form as a 500mg/50mL solution for intravenous use. It is jointly marketed by Biogen and Genentech USA, Inc. The National Drug Code (NDC) assigned to this medication is 50242-053-06.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.